Lemelson Capital Management, a private investment management firm, today announced that it has further increased its short position in Ligand ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hedge Funds Short Sales Trader Talk

Roth Still Positive on Ligand (LGND) Following Q2 Results, ASPIRE Phase 3 Update (AMGN)August 4, 2014 2:24 PM Ligand Pharmaceuticals, Inc. (LGND) Tops Q2 EPS by 10c; Boosts FY14 OutlookAugust 4, 2014 8:40 AM